An attempt has been made to determine the important criteria for evaluation of various substitute valvesfrom the standpoint ofpractical clinical experience, and to rate the broadly grouped types of valves with respect to these criteria. Stented fascia lata valves received the highest overall ranking, but, owing to their recent introduction, should probably not be generally adopted by most surgeons in preference to second and third prosthetic or homograft valves until a favourable record is proved by another two to three years of experience.
Concern and uncertainty are the prevalent attitudes to selection of the proper substitute valve for insertion after excision of diseased cardiac valves. The vantage provided by a completed decade of valvular replacement discloses a monumental record of intense activity which has had the general movement of progress. The vast number of types and models of prostheses and tissue valves which have been constructed, tested, and inserted in patients taxes the credulity of even observers close to the field, for if a comprehensive list of the various different and evolving types could be compiled it would number several hundreds.
In spite of the resulting uncertainty, the surgeon is forced to make a decision by the time the diseased valve of his patient has been excised and the field prepared for the substitute valve. A choice at the time is inescapable. Fortunately, the record of prosthetic valves and tissue valves has been generally good, and each offers the symptomatic patient with serious cardiac valvular disease a considerably improved outlook over that which would be his plight if operation were unavailable. It is appropriate to review and weigh the criteria which should be applied to the selection of the best valve and to attempt some tentative conclusions.
The proponents of the various types of prostheses and tissue valves naturally stress the importance of those very factors for which their particular valve is most outstanding. Study of the problem through these sources, therefore, can be as bewildering as the selection of the best automobile or electrical appliance on the market. Though no individual, and certainly not this author, can be suffici-4 ently authoritative to present a 'consumer's guide' in the field of valvular replacement, nevertheless the method of approach and tentative conclusions drawn by one surgeon may be of some interest and value.
General orientation
Although new valves and methods must be conceived, developed, and tested, the field in general has advanced to a degree of reliability which contradicts the widespread adoption of a new valve before at least a baseline of results which extend over a test period of two to five years or more can be presented by its proponents. Stated differently, we should be reluctant to abandon old techniques which have been tried and tested for several years and which have given reasonably good results, for new methods which may be theoretically attractive in several areas but which may in application prove to have unexpected deficiencies which outweigh the anticipated advantages. For the same reasons the time is approaching, or has arrived, when the arbitrary testing of new valve substitutes in humans without extensive preliminary evaluation in animals should be discouraged.
Another straightforward generality should be stated -namely, that the preferred operation is the one which enables the patient to remain alive and well for the longest time. Therefore the selection of the optimal substitute valve requires information concerning the late results after insertion of the various available valves. Such information is most meaningful when it includes percentages of patients alive and well in terms of elapsed time since operation. When follow-up periods of variable length are involved, only time- oriented data, such as actuarial curves, allow accurate comparison.
Criteria for comparison (see Table) Because Heterografts have the advantage over preserved homografts in that they can be harvested and prepared with very little more complexity than the manufacture of a prosthetic valve. Though each patient possesses a pulmonary autograft available for use, the extensive surgical requirement for its procurement and replacement is a strongly negative characteristic of this type of substitute valve. Fascia lata is likewise available in essentially all individuals but does require an additional incision and dissection, and the valve is constructed during the operative procedure itself.
Ease of insertion It is true that this criterion is closely related to that of assurance of function, and this analysis could be criticized for allowing the advantage of prosthetic valves in this regard to be awarded twice. However, I have retained the criterion separately because of its distinct meaning. 
